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Abstract
Background: The mammalian homologue of Seven in Absentia (Siah) can act in the ubiquitin/
proteasome pathway. Recent work has shown that Siah can bind group I metabotropic glutamate
receptors (mGluRs), but the functional consequences of this interaction are unknown.
Results: The effects of coexpression of Siah on group I mGluR signaling were examined using
heterologous expression in rat sympathetic, superior cervical ganglion neurons. Siah1a attenuated
heterologously expressed group I mGluR-mediated calcium current inhibition, but was without
effect on group II mGluR- or NE-mediated calcium current modulation via heterologously
expressed mGluR2 or native a2 adrenergic receptors, respectively, indicating that the effect of Siah
was specific for group I mGluRs. Surface expression and subcellular distribution of group I mGluRs
were not detectably altered in the presence of Siah1a as assessed by immunoflourescence
experiments with epitope tagged receptors and imaging of a GFP/mGluR fusion construct. In
addition, an N-terminal Siah deletion construct, which cannot function in the proteolysis pathway,
displayed effects similar to the wild type Siah1a. Finally, coexpression of calmodulin, which
competes with Siah1a for binding to the C-terminal tail of group 1 mGluRs, reversed the effect of
Siah1a on mGluR-mediated signaling.
Conclusions: These data supported the conclusion that the attenuation of mGluR signaling
induced by Siah1a expression was likely a direct consequence of Siah/mGluR association rather
than a result of targeting of the receptors to the proteosome. In addition, the data suggest that the
binding of CaM and Siah may play an important role in the regulation of group I mGluR function.
Background
Metabotropic glutamate receptors (mGluRs) are a family
of class 3 G protein-coupled receptors with important
functions in the regulation of synaptic transmission,
plasticity, neuronal excitability, and the regulation sen-
sory transduction [1–5]. The eight mGluRs (mGluR1-8)
and their splice variants have been divided into three
groups (I-III) based on sequence homology, pharmacol-
ogy and G protein coupling profiles [3,6,7]. Group II
(mGluR2 and 3) and III (mGluR4, and 6 through 8) cou-
ple negatively to adenylate cyclase through activation of
the Gi/o family of G proteins [8]. Group I mGluRs
(mGluR1 and 5) couple to multiple G proteins in native
and heterologous systems, and have been observed to
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be important mediators of synaptic transmission in the
brain. The group I mGluRs typically are located postsyn-
aptically (as well as in other compartments of the cell)
[16–18] where they regulate activity of ionotropic recep-
tors and are necessary in some forms of synaptic plastic-
ity [19]. The association of mGluRs with scaffolding
proteins such as Homer (group I; [20]) and PICK-1
(group III; [21]) is important in regulating mGluR local-
ization and function [21–24]. In addition to those pro-
teins involved in scaffolding, other proteins have been
shown to associate with mGluRs. For example, group I
and group III mGluRs are both known to bind Calmodu-
lin (CaM) [25,26]. In the case of group III mGluRs, the
interaction with CaM is important in regulating the effi-
cacy of G protein activation [27,28]. CaM binding to both
group I and group III mGluRs can be inhibited by serine/
threonine phosphorylation at specific sites [25,28].
Therefore, it is of interest in terms of mGluR function
and localization to understand the roles of proteins
which interact with these receptors.
The Seven in Absentia (SinA) protein was discovered in
drosophila as a mediator of photoreceptor development
[29]. Subsequently, SinA was shown to participate in the
ubiquitin/proteasome pathway [30,31]. The presence of
a RING finger domain in the N-terminus of the mamma-
lian homologue of SinA, "Siah", suggests it may be in-
volved in targeting specific proteins for degradation in
the proteasome as a ubiquitin ligase [32]. Two mamma-
lian genes encoding Siah, Siah1 and 2, are known. These
proteins have been implicated in many processes includ-
ing cancer [33], apoptosis [34] and cell cycle regulation
[35]. More recently, an interaction between Siah1a and
the C-terminal tail of group I mGluRs was demonstrated
[36]. This interaction was specific for group I mGluRs, as
it was not observed in the analogous sequences from
group II (mGluR2) or group III (mGluR7) receptors. Due
to the novelty of the mammalian homolog of Seven in
Absentia (Siah), little information is available regarding
its tissue distribution or subcellular localization in mam-
malian cells. To date the functional consequences of
Siah1a association with group I mGluRs are unknown.
To assess the role of Siah1a binding, specific group I
mGluRs were heterologously expressed in sympathetic
neurons from the rat superior cervical ganglion (SCG),
which do not natively express mGluRs [37,38]. The func-
tional role of Siah1a was assessed by examining calcium
current inhibition mediated by the expressed mGluRs in
the absence and presence of heterologous Siah1a expres-
sion. In addition, the surface expression and subcellular
distribution of group I mGluRs was examined with and
without Siah1a using various fluorescence techniques.
Finally, the effect of CaM overexpression on Siah1a func-
tion was assessed.
Results and Discussion
Coexpression of Siah1a with group I mGluRs
To examine the role of Siah1a expression on mGluR func-
tion, SCG neurons were injected with cDNA encoding
several group I mGluRs (mGluR1, 5 and their splice var-
iants) with or without Siah1a expression. Calcium cur-
rent modulation was then examined upon application of
extracellular 100 µM glutamate. The triple pulse voltage
protocol [39] was used as the standard test pulse to as-
sess calcium current magnitude and voltage dependence
of inhibition [38,40]. Figure 1A illustrates sample cur-
rent traces from before ("con") and during inhibition by
glutamate ("Glu"), in an mGluR5b-expressing cell. Con-
sistent with previous reports [24,38], calcium current in-
hibition via mGluR5b appeared partially voltage
dependent. The time course of inhibition by glutamate
and 10 µM norepinephrine (NE), acting through endog-
enous α2 adrenergic receptors [41], in this cell (figure 1B)
illustrates that inhibition was rapid and reversible.
In contrast to that in cells expressing mGluR5b alone,
calcium current inhibition by glutamate in cells coex-
pressing mGluR5b and Siah1a was quite small (figure
1C). Average inhibition of calcium currents by glutamate
in mGluR5b-expressing cells was 33 ± 5%, (n = 7). Inhi-
bition was significantly reduced to 10 ± 6% (n = 5; p <
0.05) in cells coexpressing mGluR5b and Siah1a (figure
2). This reduction of modulation by glutamate appeared
to be specific for mGluRs, as NE-mediated calcium cur-
rent inhibition was unaltered (figure ID). Calcium cur-
rent inhibition resulting from NE application in mGluR-
expressing cells was 58 ± 6% (n = 12). In cells coexpress-
ing Siah1a, NE produced an inhibition of 54 ± 6% (n = 11;
figure 2).
The strong reduction in calcium current modulation by
glutamate in the presence of Siah1a was observed with
every group I mGluR tested. Cells expressing an extracel-
lularly myc-tagged mGluR5a (mGluR5a-myc) exhibited
calcium current inhibition of 42 ± 4% (n = 6) upon gluta-
mate application. This inhibition was significantly re-
duced to 22 ± 5% (n = 6) in cells coexpressing Siah1a (p
< 0.05; figure 2). Similarly, calcium current inhibition in
cells expressing a C-terminally GFP-tagged mGluR1a
(mGluR1a-GFP) and mGluR1a-GFP + Siah1a was 46 ±
5% (n = 5) and 23 ± 6% (n = 6), respectively. In addition
to group I mGluRs, mGluR2 (a group II mGluR) was also
examined. However, Siah1a had no detectable effect on
mGluR2-mediated calcium current inhibition, consist-
ent with reports demonstrating that Siah1a does not bind
to group II mGluRs [36]. Cells expressing mGluR2 alone
exhibited 57 ± 5% inhibition of calcium current in re-
BMC Neuroscience 2001, 2:15 http://www.biomedcentral.com/1471-2202/2/15sponse to glutamate (n = 6), while those coexpressing
Siah1a were inhibited 61 ± 2% (n = 6; figure 2). Together,
these data demonstrate that in the presence of Siah1a,
the function of group I mGluRs is selectively inhibited.
These data also suggest that Siah1a is acting at the level
of the receptor, since much of the calcium current mod-
ulation through group I mGluRs proceeds through a
Gβγ-mediated pathway similar to that used by α2 adren-
ergic receptors and mGluR2 [38,40].
Effect of Siah1a on mGluR surface expression and locali-
zation
The reduction in group I mGluR signaling induced by
Siah1a expression may be attributed to several possible
mechanisms. For example, binding of Siah1a to the C-
terminus of group I mGluRs may occlude the region or
regions responsible for G protein activation. This is pos-
sible since both Siah1a binding and G protein activation
have been attributed to areas on the C-terminus of group
I mGluRs [36,42,43]. Alternatively, Siah1a binding may
alter the 'normal' interactions of the receptors with scaf-
folding proteins or may cause the receptors to be target-
ed for degradation in the proteasome, effectively
reducing the number of receptors that are 'correctly' as-
sembled, or the number of functional receptors at the
membrane. The latter hypothesis predicts a reduction in
mGluR cell surface expression or perhaps a change in
surface distribution in the presence of Siah1a, such as oc-
curs in the presence of Homer proteins [24,44,45]. To
test whether Siah1a expression altered the surface ex-
pression of group I mGluRs, the surface distribution of
mGluR5a-myc was examined in the absence and pres-
ence of Siah1a. The subcellular distribution of mGluR1a-
GFP was also examined with and without Siah1a.
Figure 3A (upper) illustrates a cell injected with cDNA
encoding mGluR5a-myc alone (and coexpressing pEGFP
as a positive marker for expression). Column 1 ("Phase")
and column 2 ("GFP") show a phase contrast image and
GFP fluorescence of such a cell. Column 3 ("anti-myc
cy3") shows surface labeling of the extracullular myc
epitope on mGluR5a-myc using a cy3 fluorescently-con-
Figure 1
Effect of Siah1a expression on mGluR-mediated calcium cur-
rent modulation. A and C, Sample current traces illustrating
calcium current before and during inhibition by 100 µM gluta-
mate in cells expressing mGluR5b (A) and mGluR5b + Siah1a
(C). A triple pulse voltage protocol was used wherein cells
were sustained at a holding potential of-80 mV and stepped
to an initial test pulse to +10 mV for 25 msec, to +80 mV for
50 msec, then following a 10 msec step to -80 mV a second
test pulse to +10 mV was applied. The scale bars indicate 20
msec and 0.4 nA. Tail currents were cropped to better illus-
trate the step currents. B and D, Time course of inhibition by
glutamate (Glu) and norepinephrine (NE) in the cells illus-
trated in A and C, respectively. Closed circles represent
measurements taken from the prepulse (the first test pulse
to +10 mV). Open circles represent measurements taken














































Siah1a effect is specific for group I mGluRs. Bar graph illus-
trating average (+SEM) calcium current inhibition via the indi-
cated receptor in the absence (filled bars) and presence
(open bars) of Siah1a. The number of cells from each group
is indicated in parentheses. * indicates a significant difference
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tibody prior to fixation to ensure that only receptors
expressed on the cell surface would be detected. Unin-
jected cells displayed no detectable cy3 labeling (data not
shown). In similarly treated cells coexpressing Siah1a,
surface expression, measured as total cell fluorescence
(figure 3B), was not significantly reduced (p = 0.33) and
no receptor clustering was observed (figure 3A, lower).
Similar experiments using a GFP-tagged group I mGluR,
GFP-mGluR1a, indicated no detectable changes in recep-
tor distribution when coexpressed with Siah1a (figure
3C). These data suggest that neither a reduction in recep-
tor levels nor a change in receptor association with scaf-
folding proteins appears to be responsible for the
diminished group I mGluR-mediated calcium current
modulation observed in the presence of Siah1a.
Does Siah1a target group I mGluRs for proteolysis?
Siah1a has been shown to be a member of the ubiquitin
family of proteins involved in protein degradation
through the proteasome [30,31,33]. Therefore, group I
mGluR degradation was considered a potential mecha-
nism for the decrease in mGluR-mediated calcium cur-
rent modulation observed in SCG neurons. Although an
obvious decrease in receptor levels in the presence of
Siah1a was not detected (figure 3), it is possible that in-
troduction of high levels of Siah1a changed the rate of
mGluR degradation such that a new equilibrium was
reached with lower levels of active receptor than in the
absence of Siah1a. Such a change may have been difficult
to detect with the fluorescence techniques used here (fig-
ure 3). Therefore, a deletion mutant of Siah1a was con-
structed, GFP-Siah1a-CT, with the N-terminal RING-
fmger domain deleted. This RING-fmger domain has
been shown to be necessary for the ubiquitination func-
tion of Siah1a [46]. As a positive control for expression,
this construct was fused to the C-terminus of GFP (figure
5A). Figure 4A illustrates sample currents from a cell ex-
pressing mGluR5a alone. As with mGluR5b, mGluR5a
produced a rapid and reversible calcium current inhibi-
tion when 100 µM glutamate was applied to the bath (fig-
ure 4B). Coexpression of GFP-Siah1a-CT caused a
significant reduction in the magnitude of calcium cur-
rent modulation via mGluR5a (figure 4C,D). Glutamate-
mediated calcium current inhibition in cells expressing
mGluR5a alone was 33 ± 4% (n = 7). In cells expressing
mGluR5a and GFP-Siah1a-CT, inhibition was reduced to
14 ± 3 (n = 6; p < 0.05; figure 5B). Therefore, a ubiquitin-
deficient Siah1a construct that can bind mGluRs is capa-
ble of producing a similar reduction in mGluR-mediated
calcium current modulation as the full length Siah1a.
This suggests that the effect of Siah1a on group I mGluRs
is a result of its physical association with the receptor,
rather than a change in receptor levels.
The role of Calmodulin
Calmodulin (CaM), a calcium binding protein intricately
involved in intracellular signaling, interacts with the C-
terminal tail of group I mGluRs [25]. This interaction ap-
pears to be dynamically regulated. Phosphorylation of
the receptors at specific sites prevents CaM binding to
mGluRs [25]. Association of Siah1a with group I mGluRs
Figure 3
Effect of Siah1a on mGluR surface expression and subcellular
distribution. A, phase contrast image, GFP fluorescence, and
surface cy3-conjugated anti-myc labeling of mGluR5a-myc
from a cell expressing mGluR5a-myc alone (upper) and a cell
coexpressing Siah1a (lower). Cy3-conjugated primary anti-
myc antibody was applied to live cells before fixation to
ensure labeling of only extracellular surface epitopes (see
methods). B, Fluorescence measurments for cells expressing
mGluR5a-myc (black bar) and mGluR5a-myc + Siah1a (open
bar), as in A. The number of cells analyzed for each group is
shown in parentheses. Units are arbitrary fluorescence units
derived from 8 bit images (see methods). No significant dif-
ference was detected between the two groups (T-Test, p >
0.3). C, Phase contrast image and GFP fluorescence from a
cell expressing mGluR1a-GFP alone (upper) and mGluR1a-
GFP with Siah1a (lower).
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[36]. This competition for binding was predicted due to
the overlap in binding sites on the C-terminal tail for
CaM and Siah1a [36]. Although CaM has been known to
associate with group I mGluRs for some time, the func-
tional role of this interaction is unknown. However, CaM
can also interact with group III mGluRs [26,28]. Recent
data suggests that the association of CaM with group III
mGluRs is necessary for normal G protein activation
[27]. By analogy to group III mGluRs, the ability of
Siah1a to compete with CaM for binding to group I
mGluRs was considered a potential mechanism for the
actions of Siah1a on group I mGluR-mediated calcium
current inhibition. Therefore, overexpression of CaM
was tested for its ability to reverse the effect of Siah1a.
Calcium current inhibition in cells expressing the group
I mGluR, mGluR5b was 29 ± 2% (figure 6; n = 21), simi-
lar to that through other group I mGluRs tested (see fig-
ure 2). Coexpression of Siah1a caused a reduction in
calcium current modulation to 12 ± 3%, as observed pre-
viously (n = 14). Next, when CaM was coexpressed with
mGluR5b and Siah1a, calcium current modulation was
significantly increased (over that in cells expressing
mGluR5b and Siah1a) to 25 ± 5% (n = 12; figure 6). Final-
ly, CaM binding to the mGluRs did not appear to be
Ca2+-dependent. When results obtained in the presence
of 11 mM EGTA, a relatively high level of Ca2+ buffering,
were compared to those in low Ca2+ buffering (with 0.1
mM intracellular BAPTA), no difference was detected.
Under low Ca2+-buffering conditions, calcium current
inhibition in control (mGluR5b alone) was 25 ± 4% (n =
9). With Siah1a and Siah1a + CaM inhibition was 7 ± 6%
(n = 3) and 30 ± 18% (n = 3), respectively. Since the re-
sults were indistinguishable with high or low Ca2+ buff-
ering, the data from both sets were pooled in the final
results (figure 6). It should also be noted that coexpres-
sion of CaM with mGluR5a in the absence of Siah1a
yields no changes in calcium current modulation (data
not shown). These results indicate that the presence of
high levels of CaM can reverse the effect of Siah1a on cal-
cium current modulation, presumably by competing for
binding on the C-terminal tail of the receptor.
The data imply two possible mechanisms for the effect of
Siah1a on mGluR signaling: First, CaM association with
group I mGluRs increases G protein coupling (or per-
haps is required, as may be the case with group III
mGluRs). This model predicts that Siah1a association
produces its effect by disrupting the interaction of CaM
with the group I mGluRs. In this case, it must be as-
sumed that under control conditions (cells heterologous-
ly expressing only the receptors), mGluRs associate with
Figure 4
Effect of GFP-Siah1a-CT on mGluR-mediated calcium cur-
rent modulation. A and C, Sample current traces illustrating
calcium current before and during inhibition by 100 µM gluta-
mate in cells expressing mGluR5b (A) and mGluR5b + Siah1a
(C). Voltage protocol was as in figure 1. The scale bars indi-
cate 20 msec and 0.5 nA (A) or 1 nA (C). Tail currents were
cropped to better illustrate the step currents. B and D, Time
course of inhibition by glutamate (Glu) in the cells illustrated
in A and C, respectively. Closed circles represent measure-
ments taken from the prepulse (the first test pulse to +10
mV). Open circles represent measurements taken from the











































Summary of GFP-Siah1a-CT effect. A, Image showing GFP
flourescence from a cell expressing GFP-Siah1a-CT. B, Bar
graph illustrating average (+SEM) calcium current via the indi-
cated receptor in the absence (filled bar) and presence (open
bar) of GFP-Siah1a-CT. The number of cells from each group
is indicated in parentheses. * indicates a significant difference
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presumably be much lower natively than in cells injected
with CaM cDNA. When Siah1a is caused to express het-
erologously (at presumably high levels) it expresses at
levels high enough to out-compete native CaM for
mGluR binding.
Alternatively, the presence of Siah1a itself may occlude G
protein coupling, with the CaM interaction being inci-
dental. Since a portion of the C-terminal tail of group I
mGluRs is involved in G protein activation [43], this
model is plausible. However, only the proximal ~20 ami-
no acids of the C-terminal tail appear to be involved in G
protein coupling. The site of Siah1a interaction is ~50
residues distal to that site [36]. Although this does not
rule out this model, it suggests that it may be less likely
than the former model, which implicates CaM as the piv-
otal interacting protein. However, until a more detailed
picture of these interactions is available, it will be diffi-
cult to answer this question definitively. Nonetheless,
the data presented here suggest a novel role for Siah1a
and CaM in regulating the function of group I mGluRs.
The notion that Siah, a putative ubiquitin ligase, would
have other roles in cell signaling is not surprising. Many
RING-finger-containing proteins that may act as ubiqui-
tin ligases under certain conditions have otherwise di-
verse structures and functions [32]. It is clear that Siah
can act in the ubiquitin pathway, targeting some proteins
for proteolysis, under certain circumstances. In addition,
the data presented here do not rule out the possibility
that Siah may target group I mGluRs to the proteasome
should they become damaged, misfolded or should other
conditions in the cell warrant mGluR proteolysis. At this
time however, there is no evidence to support this claim.
Still, it appears likely that Siah1a may play an important
role in mGluR signaling in addition to any putative func-
tion regarding the proteasome pathway.
Further studies will be needed to determine if group I
mGluRs and Siah1a interact physiologically, and wheth-
er this interaction has functional consequences. For ex-
ample, are these proteins coexpressed in certain regions
of the brain? Do they co-localize when expressed in a
particular cell type? If the results presented here can be
exprapolated to physiological situations that involve
group I mGluRs, Siah1a expression in the mammalian
nervous system could potentially play a role in cell excit-
ability by influencing mGluR-mediated potassium cur-
rent modulation (of M-type currents and perhaps of
GIRK currents), and synaptic plasticity due to the role
that group I mGluRs play in these processes [2,5,38].
Conclusions
The findings described here demonstrate that the mam-
malian homologue of seven in absentia, Siah1a regulates
the function of group I metabotropic glutamate recep-
tors. Sympathetic neurons from the rat SCG that were
made to express Siah1a with a group I mGluR attenuated
mGluR-mediated calcium current modulation. This at-
tenuation did not appear to be accompanied by a reduc-
tion in cell surface expression levels of receptor nor by an
obvious change in receptor distribution in the cells. Fur-
ther, a mutant of Siah1a was constructed with the RING
finger domain deleted, such that the protein was unable
to act in the ubiquitin/proteasome pathway [46]. This
deletion construct was as effective in attenuating group I
mGluR function as the wild type Siah1a, providing sup-
porting evidence that the effect of Siah1a resulted from
its physical association with the receptors, rather than
through a resulting reduction in receptor expression lev-
els. Finally, coexpression of CaM reversed the effect of
Siah1a on mGluR5b, indicating that the interaction of
CaM and Siah1a in binding to group I mGluRs plays a
novel and important role in mGluR function.
Figure 6
CaM reverses the effect of Siah1a on group I mGluR-medi-
ated calcium current inhibition. Bar graph illustrating average
(+SEM) calcium current via the indicated receptor in cells
expressing mGluR5b alone ("mGluR5b"), mGluR5b plus
Siah1a ("+Siah1a") and mGluR5b + Siah1a and CaM
("+CaM"). The number of cells from each group is indicated
in parentheses. * indicates a significant difference from con-
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Cell preparation and microinjection
Detailed descriptions of the isolation and injection pro-
cedures have been reported previously [47]. Briefly, the
superior cervical ganglia were dissected from adult rats
and incubated in Earle's balanced salt solution (Life
Technologies, Rochelle, MD) containing 0.45 mg ml-1
trypsin (Worthington, Freehold, NJ), 0.6 mg ml-1 colla-
genase D (Boehringer Mannheim, Indianapolis, IN) and
0.05 mg ml-1 DNAse I (Sigma, St. Louis, MO) for 1 hour
at 35°C. Cells were centrifuged twice, transferred to min-
imum essential medium (Fisher Scientific, Pittsburgh,
PA), plated and incubated at 37°C for 4 hours before
cDNA injection. Injection was performed with an Eppen-
dorf 5246 microinjector and 5171 micromanipulator
(Madison, WI) 4–6 hours following cell isolation. Plas-
mids were stored at -20 °C as a 1 µg µl-1 stock solution in
TE buffer (10 mM TRIS, 1 mM EDTA, pH 8). The
mGluR5b insert (from J.-P. Pin) was cloned in the pRK5
vector (Genentech, South San Francisco, CA). The rat
calmodulin (CaM) construct was amplified from an EST
clone (accession #AA165448) and subcloned into the pCI
vector (Promega, Madison, WI). The mGluR5a-myc
(pRK5; from P. F. Worley) has been described previously
[24]. mGluR1a-GFP was constructed by inserting the
mGluR1a cDNA into the pEGFPN1 vector (Clontech Lab-
oratories, Palo Alto, CA). Siah1a (from D. Bowtell) was in
the pcDNA3 vector (In Vitrogen, Carlsbad, CA). The
GFP-Siah1a-CT construct was made by subcloning the 3'
end of Siah1a (from base 228) into pEGFPC1 in frame. All
constructs were injected at 0.1 µg µl-1, unless otherwise
noted. Constructs were sequence verified before injec-
tion. All neurons except those injected with the
mGluR1a-GFP or GFP-Siah1a-CT constructs, were co-in-
jected with "enhanced" green fluorescent protein cDNA
(0.005 µg µl-1; pEGFP-N1; Clontech) to facilitate later
identification of successfully injected cells. Following in-
jection, cells were incubated overnight at 37°C and patch
clamp experiments were performed the following day.
Electrophysiology and data analysis
Patch clamp recordings were made using 7052 glass
(Gamer Glass, Claremont, CA). Pipette resistances
ranged from 1–3 MΩ, yielding uncompensated series re-
sistances of 2–7 MΩ. Series resistance compensation of
80% was used in all recordings. Data were recorded us-
ing an Axopatch 200A patch clamp amplifier from Axon
Instruments (Foster City, CA). Voltage protocol genera-
tion and data acquisition were performed using custom
data acquisition software on a Macintosh Quadra series
computer with a MacAdios II data acquisition board (G.
W. Instruments, Somerville, MA). Currents were sam-
pled at 0.5–5 kHz low-pass filtered at 5 kHz using the 4-
pole Bessel filter in the patch clamp amplifier, digitized,
and stored on the computer for later analysis. Experi-
ments were preformed at 21–24°C (room temperature).
Data analysis was performed using Igor software (Wave-
Metrics, Lake Oswego, OR). Statistical analyses were
performed using Statview software (SAS Institute, Cary,
NC).
In all recordings, the external (bath) solution contained
(in mM): 145 tetraethylammonium (TEA) methanesul-
fonate (MS), 10 4-(2-Hydroxy ethyl)-1-pipera-
zineethanesulfonic acid (HEPES), 15 glucose, 10 CaCl2,
and 300 nM tetrodotoxin, pH 7.4, osmolality ~320
mOsm kg-1. The internal (pipette) solution contained:
120 N-methyl-D-glucamine (NMG) MS, 20 TEA, 11 EG-
TA, 10 HEPES, 10 sucrose, 1 CaCl2, 4 MgATP, 0.1
Na2GTP, and 14 tris creatine phosphate, pH 7.2, osmola-
lity ~300 mOsm kg-1. L-glutamate (Fisher Scientific,
Pittsburgh, PA) was applied at a concentration of 100 µM
in all experiments.
Immuno fluorescence and imaging
To detect surface expression of the mGluR5a-myc con-
struct, a cy3-conjugated, mouse anti-myc antibody (Sig-
ma) was applied to live cells at room temperature for 20
minutes at a 1:150 dilution. Cells were subsequently fixed
in a 4% formaldehyde (Fisher) and 4% sucrose (Fisher)
solution in phosphate buffered saline (PBS) for 20 min-
utes, washed with PBS and imaged. Images were ac-
quired using a Spot RT Monochrome, cooled CCD
camera (Diagnostic Instruments, Inc.) mounted onto a
Nikon Eclipse TE300 inverted microscope with a 40X
objective (Nikon). Images were obtained using Spot soft-
ware (Diagnostic Instruments) and figures were con-
structed using Adobe Photoshop and Canvas (Deneba
Systems) software. Image analysis was performed using
NIH Image software. All images analyzed in figure 3B
were taken using a 3 second exposure, chosen to put the
majority of cells' fluorescence near the center of the cam-
era's dynamic range. Images of 3 cells (out of 38) were
discarded for having large areas of saturation. Using 8 bit
images, total fluorescence of a small area encompassing
the entire cell was measured and the fluorescence of an
identically sized area of background was subtracted to
yield a measure of total fluorescence for each cell. Since
there was no detectable change in cell size accompanying
Siah1a expression measured electrophysiologically (data
not shown), the fluorescence measurments were not nor-
malized to total area.
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